Tools
Change country:

Woman mourns father's nursing home death: 'He had nobody with him'

Early in the pandemic, more than 9,000 recovering coronavirus patients in New York state were released from hospitals into nursing homes under the Cuomo administration’s March 25 directive.
Read full article on: foxnews.com
Fauci says vaccine supply will "dramatically" increase in weeks ahead
The U.S. is now administering at least 2 million shots each day.
cbsnews.com
Air France passenger forces plane to make emergency landing after acting aggressive, pounding on cockpit door
Misbehavior won’t be tolerated on planes.
foxnews.com
Transcript: Benjamin Crump on "Face the Nation"
The following is a transcript of an interview with Civil Rights attorney Benjamin Crump that aired Sunday, March 7, 2020, on "Face the Nation."
cbsnews.com
It’s past time for Biden to hold a news conference
Joe Biden should show his more thoughtful, reality-based approach.
washingtonpost.com
Israel Adesanya ‘not even worth’ Jon Jones’ time after UFC 259 loss
Israel Adesanya’s foray into the UFC light heavyweight division sparked talk of a potential dream fight with Jon Jones, the longtime light-heavyweight star who is moving up to heavyweight. But Adesanya’s bid to become the UFC’s latest double champion fell short Saturday at UFC 259 as the middleweight champion lost to light heavyweight champion Jan...
nypost.com
Dana White thinks Israel Adesanya 'should focus on middleweight;' champ agrees after UFC 259
Dana White wants to see Israel Adesanya defend his middleweight title after coming up short of light heavyweight gold at UFC 259.       Related StoriesNo regrets: Israel Adesanya 'not heartbroken' about first MMA loss at UFC 259Jon Jones declares Israel Adesanya 'not even worth my time' after UFC 259 lossJon Jones declares Israel Adesanya 'not even worth my time' after UFC 259 loss - Enclosure 
usatoday.com
76ers Ben Simmons, Joel Embiid may miss NBA All-Star Game due to barber's positive COVID-19 test
Ben Simmons and Joel Embiid may be ineligible to play in All-Star Game due to contact tracing from exposure to potential COVID-19 positive individual.       
usatoday.com
1 year in: "Face the Nation" viewers on coronavirus challenges
"Face the Nation" spoke with five Americans across the country for their perspective on the COVID crisis, one year later.
cbsnews.com
Undermining mayoral control of D.C. schools won’t make things better for students
Talk about school governance is a distraction from the serious work that needs to be done.
washingtonpost.com
Daniel Kaluuya, Shaka King talk 'Judas and the Black Messiah'
Daniel Kaluuya and Shaka King join CNN's Abby Phillip to discuss how their film "Judas and the Black Messiah" is resonating decades after the killing of Chicago Black Panther leader Fred Hampton.
edition.cnn.com
Gottlieb says virus variant may cause cases to "tick back up" but surge unlikely
Dr. Scott Gottlieb, the former FDA commissioner, says the variant first detected in the U.K. "will probably cause infections to tick back up," but doesn't predict a surge.
cbsnews.com
Donald Trump Vows to Campaign in Alaska Against Lisa Murkowski in 2022
Former President Donald Trump said Saturday he would campaign against Sen. Lisa Murkowski (R-AK) in 2022 when she is due for reelection.
breitbart.com
Migrant Sex Offender Arrests Up Dramatically in One California Border Sector
San Diego Sector Border Patrol agents continue to arrest previously deported sex offenders after they illegally return to the United States. During the first five months of Fiscal Year 21, the agents arrested as many sex offenders as they did during the entire previous year.
breitbart.com
Millions of television viewers await the broadcast of Oprah Winfrey's interview with Prince Harry and Meghan, Duchess of Sussex on Sunday
edition.cnn.com
Crump says trial of Derek Chauvin, cop charged in George Floyd's death, expected to begin Monday
Attorney Ben Crump, who represents the family of George Floyd, said the family has been told that prosecutors plan to move forward with the trial as planned.
cbsnews.com
Two more women accuse New York Gov. Andrew Cuomo of sexual harassment
New York Gov. Andrew Cuomo speaks at a news conference on Sept. 8, 2020 in New York City. | Spencer Platt/Getty Images Cuomo is facing calls for his resignation amid a growing list of sexual harassment allegations. In a pair of news reports Saturday, two more former aides to New York Gov. Andrew Cuomo accused him of sexual harassment, adding to a mounting list of allegations that have spurred calls for Cuomo, a Democrat, to resign — or even to face impeachment. According to Ana Liss, a former policy and operations aide to Cuomo from 2013 to 2015, the governor repeatedly inquired about her personal life, touched her, and on one occasion even kissed her hand. Liss’s allegations were first reported by the Wall Street Journal, backed by recollections from multiple anonymous former staffers. Separately, Karen Hinton — a former Cuomo aide who also worked with the now-governor as a consultant when he led the New York Department of Housing and Urban Development — told the Washington Post Saturday that Cuomo invited her to his hotel, asked her personal questions about her marriage, and hugged her repeatedly in a manner that was “very long, too long, too tight, too intimate” when she attempted to leave. “He pulls me back for another intimate embrace,” Hinton told the Post of the encounter. “I thought at that moment it could lead to a kiss, it could lead to other things, so I just pull away again, and I leave.” Multiple people also confirmed to the Post that Hinton detailed the encounter to them shortly after it occurred in 2000, with one friend stating that Hinton was “really creeped out. It really freaked her out.” Cuomo’s office has dismissed both accounts in statements to the Wall Street Journal and to the Washington Post, casting Hinton as “a known antagonist of the Governor’s who is attempting to take advantage of this moment to score cheap points with made up allegations from 21 years ago” and claiming that hugs and kisses — the behaviors that make up the alleged inappropriate and unwanted physical contact — are just “what people in politics do.” Liss and Hinton are far from the only former aides to accuse Cuomo of sexual harassment and misconduct. Both stories are backed by additional anonymous accounts from others who have worked with or for Cuomo — including that of a federal official who told the Post Cuomo kissed her on the cheek in front of colleagues shortly after she began work at HUD — and they are the fourth and fifth named accusers to emerge in recent weeks. Previously, two other former aides — Lindsey Boylan, now a candidate for Manhattan Borough President, and Charlotte Bennett — accused Cuomo of sexual harassment. A third woman, Anna Ruch, who did not work Cuomo, recounted meeting the governor at a friend’s wedding, and says he attempted to kiss her. Whoa at this pic: A young woman says Gov. Andrew Cuomo asked if he could kiss her at a wedding, and put his hands on her faceAnna Ruch said she felt “uncomfortable and embarrassed” when he did this https://t.co/oxb5fbBqO3 pic.twitter.com/4IdxDp62WL— philip lewis (@Phil_Lewis_) March 2, 2021 Ruch’s allegations are also backed by a photo of the encounter. Her story, as well as Bennett’s, was first reported by the New York Times. Boylan first accused Cuomo of misconduct in an essay posted to Medium in February this year. According Bennett, Cuomo asked her about her sex life and whether she was interested in older men, among other comments. “I understood that the governor wanted to sleep with me, and felt horribly uncomfortable and scared,” Bennett told the Times of a June 5 encounter with Cuomo in his Albany office. “And was wondering how I was going to get out of it and assumed it was the end of my job.” Cuomo is facing a flurry of misconduct allegations right now In addition to a slew of sexual harassment allegations, Cuomo is also facing at least two other closely linked scandals that have left his political career in jeopardy. One revolves around his handling of the Covid-19 pandemic in New York: Despite a star turn for Cuomo early in the crisis, when New York City was by far and away the hardest-hit area of the country, new reports suggest that the Cuomo administration deliberately manipulated nursing home death statistics to cast New York’s response in a more favorable light — and to shield the governor from criticism. According to the New York Times, Cuomo aides — none of whom had a background in public health — rewrote a report first produced by New York state health officials to remove a statistic revealing how many nursing home residents died from the virus in the state. Additionally, a report by New York Attorney General Letitia James found that the Cuomo administration initially undercounted those nursing home deaths by as much as 50 percent, according to the New York Times. After the attorney general’s report was released in late January, the state provided new data that increased the reported number of nursing home deaths in New York by more than 40 percent. Cuomo’s response to the nursing home scandal has also spun off into a scandal in its own right: In February, New York Assemblyman Ron Kim, who is also a Democrat, said Cuomo allegedly threatened Kim’s career in politics over Kim’s criticism of Cuomo’s handling of nursing home deaths in New York, and comments Kim made to the New York Post detailing a call Cuomo aide Melissa DeRosa had with lawmakers about the deaths. “Gov. Cuomo called me directly on Thursday to threaten my career if I did not cover up for Melissa and what she said. He tried to pressure me to issue a statement, and it was a very traumatizing experience,” Kim told CNN last month. Kim also alleges that Cuomo told him, “We’re in this business together and we don’t cross certain lines, and he said I hadn’t seen his wrath and that he can destroy me.” Kim’s account has since sparked the revelation of a number of other similar stories about Cuomo from New York politicians, which were bolstered by Saturday’s Washington Post story about Hinton. According to the Post, Cuomo “was often consumed by rage and irritation toward [staffers], only to be kind and charming in their next interactions. They found the sharp contrast to be deeply disorienting, with some saying it even drove colleagues to suffer emotional breakdowns.” In the same story, Kim told the Washington Post that Cuomo’s behavior was a pattern. “He feels untouchable,” Kim said of Cuomo. “Whether it’s verbal or physical abuse, or threatening lawmakers or journalists for doing their jobs, it’s come to a level where it’s so normalized that he doesn’t think twice about behaving that way.” Cuomo says he isn’t going anywhere Despite the mounting and diverse set of misconduct allegations facing Cuomo, it’s unclear what the future holds for him. James, the New York attorney general, has opened an independent civil investigation into sexual harassment allegations against Cuomo, and Saturday’s revelations could intensify pressure on the governor to step down of his own accord. Already, at least one member of New York’s congressional delegation, Rep. Kathleen Rice, has called for Cuomo to resign. The time has come. The Governor must resign. https://t.co/GjcvuNfpfQ— Kathleen Rice (@RepKathleenRice) March 2, 2021 And on Thursday, New York’s Senate Majority Leader, Andrea Stewart-Cousins, indicated that she too would call for Cuomo’s resignation if more sexual harassment allegations surfaced. Since then, two more women — Liss and Hinton — have gone on the record accusing Cuomo of sexual misconduct. Thus far, however, Cuomo has resisted calls to resign, though he issued an apology of sorts at a press conference Wednesday. “I have learned from what has been an incredibly difficult situation, for me as well as other people, and I’ve learned an important lesson,” Cuomo said Wednesday. “I’m sorry for whatever pain I caused anyone. I never intended it, and I will be the better for this experience.” Even if Cuomo does stay in office, the recent tide of scandals could undercut his political future in the state. He will be up for reelection in 2022, if he does choose to seek a fourth term as New York governor, and as Politico points out, he might well face a difficult primary to claim the Democratic gubernatorial nomination. “Whether he resigns or not, there will be no shortage of candidates in 2022,” one anonymous source told Politico of Cuomo’s plight. “Donors and consultants have begun reaching out to prospective candidates because they see the writing on the wall.” Finally, Cuomo’s eventual political fate could have far broader implications for the Democratic Party: As Vox’s Anna North has written, “what happens next” — whether resignation, impeachment, or an eventual primary repudiation — “will show how Democrats handle sexual misconduct allegations against one of their own more than three years after the Me Too movement started making headlines.”
vox.com
Golden Globes Vows Reform Amid Scrutiny on Diversity
The HFPA said Saturday that it would focus on adding Black and other underrepresented members to its organization
time.com
WHO says Europe sees 1 million new COVID cases as virus surges
CBS News senior foreign correspondent Elizabeth Palmer reports from London on the global impacts of COVID-19.
cbsnews.com
Biden opposes gutting filibuster despite tough path for some legislative priorities in Senate
President Joe Biden opposes ending the legislative filibuster despite a slim Democratic majority in the Senate, White House communications director Kate Bedingfield said Sunday, as the administration faces hurdles in pushing the President's priorities through Congress.
edition.cnn.com
Idahoans burn masks at State Capitol; Dalai Lama vaccinated: Live COVID-19 updates
Idahoans burned masks at the State Capitol in Boise to protest health recommendations they view as restrictions on freedom. Latest COVID-19 news.      
usatoday.com
'Wander Darkly' was born from a head-on crash, chaotic family life, endless gratitude
It took writer-director Tara Miele seven years to distill the emotions that followed a car collision to see 'Wander Darkly' completed.
latimes.com
How to Watch Prince Harry and Meghan Markle’s Oprah Interview
The interview is expected to be a one-night-only event, so don't miss it.
nypost.com
Joel Embiid, Ben Simmons could miss NBA All-Star Game after barber’s COVID-19 test
Joel Embiid and Ben Simmons could be ruled ineligible to play in the NBA All-Star Game on Sunday night due to exposure to an individual who recently tested positive for COVID-19. Eastern Conference coach Doc Rivers said “it’s not looking great” for the two Philadelphia 76ers stars, who are facing contact tracing after exposure to...
nypost.com
The Differences Between the Vaccines Matter
Public-health officials are enthusiastic about the new, single-shot COVID-19 vaccine from Johnson & Johnson, despite its having a somewhat lower efficacy at preventing symptomatic illness than other available options. Although clinical-trial data peg that rate at 72 percent in the United States, compared with 94 and 95 percent for the Moderna and Pfizer-BioNTech vaccines, many experts say we shouldn’t fixate on those numbers. Much more germane, they say, is the fact that the Johnson & Johnson shot, like the other two, is essentially perfect when it comes to preventing the gravest outcomes. “I’m super-pumped about this,” Virginia’s vaccine coordinator told The New York Times last weekend. “A hundred percent efficacy against deaths and hospitalizations? That’s all I need to hear.”The same glowing message—that the COVID-19 vaccines are all equivalent, at least where it really counts—has been getting public-health officials and pundits super-pumped for weeks now. Its potential value for promoting vaccination couldn’t be more clear: We’ll all be better off, and this nightmare will be over sooner, if people know that the best vaccine of all is whichever one they can get the soonest. With that in mind, Vox has urged its readers to attend to “the most important vaccine statistic”—the fact that “there have been zero cases of hospitalization or death in clinical trials for all of these vaccines.” The physician and CNN medical analyst Leana Wen also made a point of noting that “all of the vaccines are essentially a hundred percent” in this regard. And half a dozen former members of President Joe Biden’s COVID-19 Advisory Board wrote in USA Today, “Varying ‘effectiveness’ rates miss the most important point: The vaccines were all 100% effective in the vaccine trials in stopping hospitalizations and death.”There’s a problem here. It’s certainly true that all three of the FDA-authorized vaccines are very good—amazing, even—at protecting people’s health. No one should refrain from seeking vaccination on the theory that any might be second-rate. But it’s also true that the COVID-19 vaccines aren’t all the same: Some are more effective than others at preventing illness, for example; some cause fewer adverse reactions; some are more convenient; some were made using more familiar methods and technologies. As for the claim that the vaccines have proved perfectly and equally effective at preventing hospitalization and death? It’s just not right.These differences among the options could matter quite a bit, in different ways to different people, and they should not be minimized or covered over. Especially not now: Vaccine supplies in the U.S. will soon surpass demand, even as more contagious viral variants spread throughout the country. In the meantime, governors are revoking their rules on face masks, or taking other steps to loosen their restrictions. It’s tempting to believe that a simple, decisive message—even one that verges on hype—is what’s most needed at this crucial moment. But if the message could be wrong, that has consequences.The idea that all of the vaccines are pretty much the same, in that they’re perfect at preventing COVID-19 hospitalizations and death, got its legs on social media. The USA Today op-ed by the former members of the Biden team illustrated this by linking to a data table found on Twitter. Created by the infectious-disease doctor Monica Gandhi, it showed a variety of trial results for six different vaccines. One column was rendered in canary yellow—“Protection from hospitalizations/death”—and every cell read “100%.” A similar table, tweeted out a few days earlier by the dean of Brown University’s School of Public Health, Ashish Jha, conveyed the same idea through a grid of zeros—as in, zero people hospitalized, zero people dead. The prominent physician and researcher Eric Topol followed with his own clinical-trial data summary featuring a column of 100 percents. “That is impressive!” he wrote across the top. All told, their posts would be retweeted about 15,000 times.The data were indeed suggestive of an encouraging idea. Based on the numbers so far, we can expect the vaccines to provide extremely high levels of protection against the most dire outcomes. Still, we don’t know how high—and it’s clear they won’t uniformly cause hospitalizations and deaths from COVID-19 to disappear in vaccinated people.The experts understand this, of course. Gandhi has been updating her table as more data come in, and now pegs Moderna’s efficacy on that front at 97 percent; Jha has since tweeted that “nothing is 100 percent … But these vaccines sure are close”; and Topol told The Atlantic that the numbers in his tweet are not a sufficient basis from which to draw “any determination of magnitude of effect,” though the fact that they all point in the same direction is “very encouraging.” Still, the message of perfection that their initial tables and tweets spawned—the gist, for many readers, of all those 100s and zeros—has since been picked up far and wide, and misinterpreted along the way.To grasp the shaky nature of these particular data, it’s important to remember how the vaccine-development process began. Last April, not long after the pandemic began, the World Health Organization set out a target efficacy for vaccines of 50 percent, with options for how that value should be measured. A vaccine could be shown to reduce the risk of symptomatic disease, severe disease, or transmission of the coronavirus. The FDA offered similar guidance in June, and other regulatory agencies also followed the WHO’s lead. Among these choices, symptomatic disease was the most feasible, because it’s both a common outcome and one that’s easier to confirm in a large-scale trial. An outcome that included asymptomatic infections would have been even more common, but screening for all infections would have been prohibitive, especially early in the pandemic. So that’s how the vaccine trials were designed: Each would try to demonstrate at least 50 percent efficacy with respect to symptomatic disease as its “primary outcome.”The trials could have used severe disease, hospitalization, or death as primary outcomes, but that would have slowed things down. These events are far more infrequent—there could have been 200 infections for each COVID-19 death in the U.S.—and that means it would have taken more time, and larger numbers of trial participants, to generate enough data to be sure of a 50 percent efficacy. Developers did include “severe COVID-19” as a secondary outcome—that is, one that would be measured and analyzed, but for which the trial might not have been designed to provide a definitive answer. Efficacy against hospitalization and against death, however, were not included as secondary outcomes for every trial.Given that fact, the data can’t support a claim that the vaccines are 100 percent effective at preventing these serious outcomes. (Topol highlighted this very issue in an op-ed last fall for The New York Times.) Out of the six vaccines included in the dramatic data tables that made the rounds on Twitter, the clinical trials for only two of them—Oxford-AstraZeneca’s and Johnson & Johnson’s—included hospitalization for COVID-19 as a secondary outcome, and reported that efficacy rate. The clinical research for one other vaccine, made by Novavax, had hospitalization as a secondary outcome, but that trial hasn’t been reported in full yet. (On my website, I’ve provided more detailed information and analysis of the relevant data.)Now, a casual reader of clinical-trial reports—or their summaries on social media—might take the fact that no hospitalizations of vaccinated people are mentioned to mean that none occurred. That’s risky, given that pieces of the data have been published across various medical journals and via several different regulatory agencies rather than in full in one place; that the plans for some trials did not specify ahead of time that the vaccine’s efficacy at preventing hospitalizations would be calculated; and that we’ve seen only minimal early data (via a press release from Novavax) from one of them. It would be just as risky to assume that all hospitalizations would be included in the analyses of people who developed severe COVID-19. Hospitalization and severe disease are not synonymous—people could be coping at home even though COVID-19 has caused their oxygen levels to drop severely, and moderately ill people might be hospitalized out of an abundance of caution when they are at high risk of getting worse.The two vaccine trials that did explicitly report hospitalizations as an efficacy outcome make this latter issue very clear. For the AstraZeneca vaccine, one person in the control group had severe COVID-19, but eight people were hospitalized; for Johnson & Johnson, 34 people in the placebo group had severe COVID-19, but only five people were hospitalized. It’s true that zero vaccinated people were hospitalized in either study after the vaccines took effect. But with numbers that small, you can’t draw a reliable conclusion about how high efficacy may be for these outcomes. As Diana Zuckerman of the National Center for Health Research pointed out about the Johnson & Johnson trial, “It’s misleading to tell the public that nobody who was vaccinated was hospitalized unless you also tell them that only 5 people in the placebo group were hospitalized.” She’s right. And you can’t be confident about predicting effectiveness precisely in a wider population outside the trial, either. For example, some of the vaccine trials included relatively few people older than 60 as participants.You can see how fragile these numbers are by looking at those compiled for severe disease. In the Pfizer trial, for example, just one vaccinated person developed severe COVID-19 versus three in the placebo group—which meant that a single bout of disease made the difference between a calculated efficacy rate of 66 percent and one of 100 percent. For the Novavax and Oxford-AstraZeneca trials, there were zero people with severe disease in the vaccinated group versus only one in the control group, so adding or subtracting one would have been even more dramatic. The problem is even greater for deaths. For that efficacy analysis, only two of the vaccine trials—for Moderna’s and Johnson & Johnson’s—reported any COVID-19 deaths at all in the control groups.It’s also important to remember that these are early results: Some people who enrolled very late in the trials aren’t yet included in reported data, and analysis is still under way. Indeed, the FDA pointed out in December that one vaccinated person in the Moderna trial had been hospitalized with apparently severe COVID-19 two months after receiving a second dose. That person was in a group still awaiting final assessment by the researchers, and was not mentioned in Moderna’s formal readout of results.We’ve learned a little more from the ongoing public vaccination programs. Four important reports have come in the past two weeks. In one, researchers compared about 600,000 people who had had a full course of the Pfizer vaccine in Israel with 600,000 people matched in age and other demographics who had not been vaccinated. The shots’ effectiveness at preventing hospitalization was measured at 87 percent. (“This vaccine is fabulous in a real world setting,” Jha tweeted in response.) A preprint from Scotland reported an efficacy rate against hospitalization of about 80 percent among people 80 or older, almost all of whom had received only one dose of either the Pfizer or the AstraZeneca vaccine. Two reports from Public Health England estimated a reduction of hospitalization of about 50 percent and 43 percent for the same age group, again almost all after just one dose of the Pfizer vaccine. These are exciting outcomes—those vaccines really, really worked! But they oughtn’t lead anyone to think that the vaccines are all the same, and that protection will be perfect.Where does that leave us for making decisions? As Anthony Fauci told The New York Times last weekend, “Now you have three highly effective vaccines. Period.” Again, you will get a lot of benefit from any of them, and your risk will shrink even more as those around you get vaccinated too. Whichever one you start with, a booster may be coming in the not-so-distant future, of the same vaccine or perhaps a different one. By taking the first vaccine you can get, you’ll also avoid the risk of finding yourself without protection if infection rates surge where you live.Efficacy is merely one layer, though. The Pfizer and Moderna vaccines have an edge at preventing symptomatic illness, but the Johnson & Johnson vaccine brings its own advantages. It has no demanding freezer requirements, which means it’s easier to distribute and more accessible to many communities. It’s more affordable than the other two—the company is providing it at cost around the world. Then there’s the fact that resources can be stretched a lot further when only a single dose has to be administered.For individuals, too, the Johnson & Johnson vaccine has benefits. As a one-and-done injection, it’s more convenient. It also has a lower rate of adverse events than Moderna’s. You can’t compare results of these trials too precisely, but there are indications of a striking difference. About 2 percent of those who got the Johnson & Johnson vaccine recorded having reactions, such as fatigue, muscle aches, and fever, that were severe enough to interfere with daily activities. For those getting their second injection of Moderna, that rate was higher than 15 percent. People who are on the fence about getting vaccinated may find that this difference tips the scales in favor of getting a shot. Others who have doubts about the newness of the mRNA technology in the Pfizer and Moderna vaccines may appreciate the fact that Johnson & Johnson’s approach has already been deployed in the company’s Ebola vaccine, which got full drug approval in Europe last year.Given these concerns, there’s some danger in the message—however well intentioned—that the COVID-19 vaccines are all the same by any measure, or that they’re perfect wards against severe disease. Vaccination is a public-health imperative, and going full tilt to promote uptake supports the common good. But it’s a personal health decision too. People want to protect themselves and those close to them, and they are likely to care about outcomes other than hospitalization and death, no matter what anyone says now.Still, raising these concerns in public can be fraught. In response to an inquiry about her data table, Gandhi affirmed the importance of looking at severe-disease outcomes and noted that “careful, collegial and collaborative scientific discourse on the vaccines is imperative moving forward to help us get through the pandemic.” Topol pointed out that he has emphasized the vaccines’ measured efficacy against symptomatic disease many times before, so any isolated reference to his table “takes that particular post out of context.” Jha wrote in an email that he stands by the message of his original tweet, and notes that COVID-19 hospitalizations and deaths are so rare among the people vaccinated in these trials, to quibble over differences is akin to “counting how many angels are dancing on the head of the pin.”I can see why this might seem like quibbling, but I just don’t think it’s a trivial matter. It would be different if I thought the effectiveness of every one of those six vaccines against hospitalizations and death would really end up being close to 100 percent—or if I bought into the idea, now widespread, that they have already been shown to “nearly” or “effectively” eliminate these outcomes. There is very good reason to be encouraged by the data, but to say right now that people who have been vaccinated face zero risk of serious outcomes—that, for them, COVID-19 is no more dangerous than the common cold—is sure to influence behavior. Imagine how people in high-risk groups would feel about going to the movies, or how their employers would feel about putting resources into workplace safety, if we all assumed that vaccines confer perfect protection against hospitalization or death. Now imagine how the same people and employers would feel knowing they were 85 percent protected.Nor is there any reason to believe that the public or the personal interest will be served by hype. People who think the vaccines provide ironclad protection may lose trust in experts if reality falls short. Trust in coronavirus-vaccine information is already a problem, and could sink even lower. Activists who are opposed to vaccination may end up turning experts’ “super-pumped” promises against them.“The idea that people can’t handle nuance,” Jha tweeted at the end of February, “it’s paternalistic. And untrue.” I couldn’t agree more. The principle of treating people like adults is fundamental. We don’t need to exaggerate. Talking about the trade-offs between different medicines and vaccines is often complicated, but we do it all the time—and we can do it with COVID-19 vaccines too.
theatlantic.com
NBC's Alcindor: Biden Admin Says No Crisis At the Border -- 'But the Numbers Don’t Lie'
PBS correspondent and NBC political contributor Yamiche Alcindor said Sunday on NBC's "Meet the Press" that while the Biden administration does not want to say there is a crisis on the U.S.-Mexico border, the numbers of people crossing "don't lie."
breitbart.com
Tesla is about to unveil an updated Cybertruck, Elon Musk says
It's been more than a year since Tesla unveiled the first version of its electric Cybertruck, but Tesla CEO Elon Musk said an updated version of the car might be coming soon.
edition.cnn.com
Not all your money belongs to you: Profits are rising in IRAs and 401(k)s, but so are future taxes
Putting money into retirement accounts on a pretax basis doesn't mean you will avoid paying Uncle Sam eventually. Here's what to know.      
usatoday.com
Queen Urged to Apologise to Meghan Markle on 'The View'
Co-hosts on top American talk show 'The View' urged the Queen, senior royals, and royal staff to apologise to Meghan Markle, wife of Prince Harry, rather than investigate bullying allegations against her.
breitbart.com
As the George Floyd Murder Trial Begins, Here's What You Need to Know
The trial of Derek Chauvin, the former Minneapolis police officer charged in Floyd's death, begins with jury selection on March 8.
newsweek.com
68% of Americans Support Biden's Pandemic Response, Most Say Lifting COVID Restrictions Too Fast
The president's approval rating regarding his management of the COVID-19 pandemic has been consistent since he took office in January.
newsweek.com
How to watch Oprah's interview with Harry and Meghan
Grab your tea and crumpets: Oprah Winfrey's long-awaited interview with Prince Harry and Meghan Markle airs Sunday night.
edition.cnn.com
Transcript: Phil Murphy on "Face the Nation"
The following is a transcript of an interview with New Jersey Governor Phil Murphy that aired Sunday, March 7, 2021, on "Face the Nation."
cbsnews.com
West Virginia Governor Jim Justice defends mask mandate as some states pull back
Republican Governor Jim Justice says mask mandates are needed "for us to get on rock-solid ground."
cbsnews.com
Narrow relief bill victory provides warning signs for broader Democratic agenda
The triumph belied the broader challenges facing President Biden as he tries to navigate intraparty divisions to push through an ambitious agenda on voting rights, climate change, immigration and other issues.
washingtonpost.com
Washington Nationals release reliever Jeremy Jeffress
Jeffress, 33, was with the team for about two weeks before the Nationals let him go.
washingtonpost.com
Les Miles’ attorney rips Kansas’ response to sexual harassment allegations
An attorney for Les Miles says allegations by female students and staffers of inappropriate behavior when he was the football coach at LSU are untrue, and they plan to fight his placement on administration leave Friday by Kansas. Attorney Peter Ginsberg said in a statement that Kansas’ decision was “bending to the winds of media...
nypost.com
How to watch Oprah's interview with Harry and Meghan
Grab your tea and crumpets: Oprah Winfrey's long-awaited interview with Prince Harry and Meghan Markle airs Sunday night.
edition.cnn.com
White House Coronavirus Response Official Calls Vaccine Distribution Inequality 'Unacceptable'
Jeffrey Zients outlined the Biden administration's plans to continue addressing the country's inequitable vaccine rollout in comments to NBC News' Chuck Todd on Sunday.
newsweek.com
COVID-19 pill effective in preliminary testing may be 'holy grail' of pandemic, Dr. Marc Siegel says
A new possible medication to treat coronavirus-positive patients could be enough to turn the pandemic on its head, Fox News medical contributor Dr. Marc Siegel revealed Sunday on "Fox & Friends Weekend."
foxnews.com
CNN's Chris Cuomo to Don Lemon: 'You Know I'm Black on the Inside'
CNN's anchor Chris Cuomo said "I'm black on the inside" during the handover segment with his colleague Don Lemon on Friday, as he cited the words of the theme song from the 1970s program "Good Times."
breitbart.com
GOP Senator John Barrasso Backs Lisa Murkowski Despite Trump's Threat Against Her
The Wyoming Republican praised Murkowski on Sunday after Trump called her "disloyal" and "very bad" and promised to campaign against her in Alaska next year.
newsweek.com
Callista and Newt Gingrich: America needs Dr. Seuss – and our children deserve him
Learning to read is one of the first opportunities children have to develop their minds, learn about the world, and become happy, well-rounded people. 
foxnews.com
Fauci says vaccine supply will be "dramatically increased" in weeks ahead
Dr. Anthony Fauci says the CDC will soon issue guidance on how vaccinated individuals should interact with others.
1 h
cbsnews.com
New Jersey Governor Phil Murphy says nursing homes who didn't follow virus guidance should "pay a price"
New Jersey Governor Phil Murphy says he is "confident" in his state's tally of deaths in nursing homes during the pandemic.
1 h
cbsnews.com
Open: This is "Face the Nation," March 7
Today on "Face the Nation," the month of March brings new hope, but also new warnings not to go too far, too fast when it comes to lifting restrictions due to the coronavirus.
1 h
cbsnews.com
What Is Amy Poehler’s Netflix Movie ‘Moxie’ About And Why Is It Trending Among Teens?
This brilliant homage to feminism couldn't have been timed more perfectly during Women's History Month.
1 h
nypost.com
Jan Blachowicz would like 'respect from everybody' after beating Israel Adesanya at UFC 259
Jan Blachowicz wants his proper due after handing Israel Adesanya his first loss in the UFC 259 headliner.       Related StoriesNo regrets: Israel Adesanya 'not heartbroken' about first MMA loss at UFC 259With Holly Holm out, Julianna Pena wants Amanda Nunes fight – and Dana White is considering itWith Holly Holm out, Julianna Pena wants Amanda Nunes fight – and Dana White is considering it - Enclosure 
1 h
usatoday.com
Column: Stanley Tucci is magical. Why does his Italy travel show leave me so enraged?
A year into the pandemic, shows that let us travel vicariously have become as irritating as they are illuminating — so we're getting back to normal.
1 h
latimes.com